Hey PA, I think it may be quite some time before there is any significant rise in price here, personally I have written this investment off, but still have an interest in there technology. As Virax have stated, shareholders will not be paying for any further research with VIR201. The Royalties from Transgene are limited at best currently. The next real price rise (company make of break) will be in the first half of next year, all else is survival.
VHL Price at posting:
2.7¢ Sentiment: None Disclosure: Held
